EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcome

Ojaswita Lokre iD, Timothy G Perk, Amy J Weisman, Rajkumar Munian Govindan, Song Chen, Meijie Chen, Jens Eickhoff, Glenn Liu, Robert Jeraj

European Journal of Nuclear Medicine and Molecular Imaging · 2024-10 · 51 (12) · 3505-3517

DOI: 10.1007/s00259-024-06764-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 31.05.2024. Verfasst von Ojaswita Lokre und 8 weiteren Autor:innen. Beteiligte Einrichtung: AIQ Solutions, 8000 Excelsior Dr Suite 400, Madison, WI, 53717, United States of America. ojaswita.lokre@aiq-solutions.com. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Standardized reporting of treatment response in oncology patients has traditionally relied on methods like RECIST, PERCIST and Deauville score. These endpoints assess only a few lesions, potentially overlooking the response heterogeneity of all disease. This study hypothesizes that comprehensive spatial-temporal evaluation of all individual lesions is necessary for superior prognostication of clinical outcome. Methods [ 18 F]FDG PET/CT scans from 241 patients (127 diffuse large B-cell lymphoma (DLBCL) and 114 non-small cell lung cancer (NSCLC)) were retrospectively obtained at baseline and either during chemotherapy or post-chemoradiotherapy. An automated TRAQinform IQ software (AIQ Solutions) analyzed the images, performing quantification of change in regions of interest suspicious of cancer (lesion-ROI). Multivariable Cox proportional hazards (CoxPH) models were trained to predict overall survival (OS) with varied sets of quantitative features and lesion-ROI, compared by bootstrapping with C-index and t-tests. The best-fit model was compared to automated versions of previously established methods like RECIST, PERCIST and Deauville score.

Results

Multivariable CoxPH models demonstrated superior prognostic power when trained with features quantifying response heterogeneity in all individual lesion-ROI in DLBCL (C-index = 0.84, p < 0.001) and NSCLC (C-index = 0.71, p < 0.001). Prognostic power significantly deteriorated ( p < 0.001) when using subsets of lesion-ROI (C-index = 0.78 and 0.67 for DLBCL and NSCLC, respectively) or excluding response heterogeneity (C-index = 0.67 and 0.70). RECIST, PERCIST, and Deauville score could not significantly associate with OS (C-index < 0.65 and p > 0.1), performing significantly worse than the multivariable models ( p < 0.001).

Conclusions

Quantitative evaluation of response heterogeneity of all individual lesions is necessary for the superior prognostication of clinical outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyLung NeoplasmsCarcinoma, Non-Small-Cell LungLymphoma, Large B-Cell, DiffuseFluorodeoxyglucose F18HumansMaleFemaleMiddle AgedPrognosisAgedTreatment OutcomeRetrospective StudiesAdult

Stichwörter der Autor:innen

Clinical imagingComputational methodsFDG PET/CTLung cancerLymphomaPrognostication of clinical outcomeTumor heterogeneity

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • AIQ Solutions, 8000 Excelsior Dr Suite 400, Madison, WI, 53717, United States of America. ojaswita.lokre@aiq-solutions.com.
  • AIQ Solutions, 8000 Excelsior Dr Suite 400, Madison, WI, 53717, United States of America.
  • Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Medical Physics, University of Wisconsin-Madison, Madison, WI, United States of America.

ORCID-Profile: Ojaswita Lokre

Förderung

  • NCI NIH HHS

Zitieren

APA

Lokre, O., Perk, T. G., Weisman, A. J., Govindan, R. M., Chen, S., Chen, M., Eickhoff, J., Liu, G., & Jeraj, R. (2024). Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcome. European Journal of Nuclear Medicine and Molecular Imaging, 51(12), 3505-3517. https://doi.org/10.1007/s00259-024-06764-0

Vancouver

Lokre O, Perk TG, Weisman AJ, Govindan RM, Chen S, Chen M, et al. Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcome. European Journal of Nuclear Medicine and Molecular Imaging. 2024;51(12):3505-3517. doi:10.1007/s00259-024-06764-0

BibTeX
@article{Lokre2024,
  author = {Lokre, Ojaswita and Perk, Timothy G and Weisman, Amy J and Govindan, Rajkumar Munian and Chen, Song and Chen, Meijie and Eickhoff, Jens and Liu, Glenn and Jeraj, Robert},
  title = {Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcome},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  volume = {51},
  number = {12},
  pages = {3505--3517},
  doi = {10.1007/s00259-024-06764-0}
}
Kostenlos starten →